Administration of TXA Is Not Associated with Increased Risk of Thromboembolism, Even in Patients Considered High Risk: Commentary on an article by Steven B. Porter, MD, et al.: "Tranexamic Acid Was Not Associated with Increased Complications in High-Risk Patients with Intertrochanteric Fracture". uri icon

Overview

publication date

  • July 6, 2022

Research

keywords

  • Antifibrinolytic Agents
  • Hip Fractures
  • Thromboembolism
  • Tranexamic Acid

Identity

Scopus Document Identifier

  • 85133639865

Digital Object Identifier (DOI)

  • 10.2106/JBJS.22.00450

PubMed ID

  • 35793800

Additional Document Info

volume

  • 104

issue

  • 13